April 14, 2021
Business News

FDA Issues Emergency Use Authorization for Third COVID-19 Vaccine – FDA.gov

For Immediate Release:
February 27, 2021
Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the third vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The EUA allows the Janssen COVID-19 Vaccine to be distributed in the U.S for use in individuals 18 years of age and older.
The authorization of this vaccine expands the availability of vaccines, the best medical prevention…

Click here to view the original article.

Related Posts

You might also like ...

L3Harris Technologies and American Rheinmetall Vehicles Team to Pursue US Army’s New Fighting Vehicle
ADAPTHEALTH ALERT: Bragar Eagel & Squire, P.C. Is Investigating AdaptHealth Corporation on Behalf AdaptHealth Stockholders and Encourages Investors to Contact the Firm
Semiconductor Energy Laboratory and Silvaco Jointly Develop SPICE Model of Oxide Semiconductor FETs